Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

Fabian PROFT, Fellow, Charité Universitätsmedizin Berlin, Berlin, Charité, Department of Gastroenterology, Infectiology and Rheumatology

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study - Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd

PDF) Measuring disease activity in ankylosing spondylitis: Patient and physician have different perspectives

POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES

Ankylosing Spondylitis: Most Up-to-Date Encyclopedia, News & Reviews

SciELO - Brasil - Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort Effectiveness and safety of secukinumab in ankylosing spondylitis and

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study - Julia Schally, Henning Christian Brandt

Asdas: Ankylosing Spondylitis Disease Activity Score

PDF) Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable